Raymond James Financial
CRBU icon

Raymond James Financial’s Caribou Biosciences CRBU Stock Holding History

Raymond James Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.1K Buy
+16,373
New +$28.1K ﹤0.01% 5168
2025
Q3 		– Sell
-8,727
Closed -$11K – 5338
2025
Q2 		$11K Buy
+8,727
New +$8.58K ﹤0.01% 5887

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James Financial's CRBU Position: Q1 2026 in Review

Raymond James Financial opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 16,373 shares worth $31.1K. The stake represents ﹤0.01% of the portfolio and ranks #5168 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in CRBU as recently as Q2 2025.

Raymond James Financial first reported a position in CRBU in Q2 2025 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Raymond James Financial held 16,373 shares of Caribou Biosciences worth $31.1K as of Q1 2026.
  • Caribou Biosciences was a new Raymond James Financial position in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5168 holding.
  • Raymond James Financial first reported a position in Caribou Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.